B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis

NCT02376335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Fatigue
Primary Biliary Cirrhosis

Interventions

BIOLOGICAL: Rituximab
OTHER: Placebo

Sponsor

Newcastle-upon-Tyne Hospitals NHS Trust

Collaborators

[object Object]
[object Object]
[object Object]